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Abstract
Increased adipose tissue macrophages contribute to obesity-induced metabolic syndrome. Heme oxygenase-1 (HO-1) is a
stress-inducible enzyme with potent anti-inflammatory and proangiogenic activities in macrophages. However, the role of
macrophage HO-1 on obesity-induced adipose inflammation and metabolic syndrome remains unclear. Here we show that
high-fat diet (HFD) feeding in C57BL/6J mice induced HO-1 expression in the visceral adipose tissue, particularly the stromal
vascular fraction. When the irradiated C57BL/6J mice reconstituted with wild-type or HO-1
+/2 bone marrow were fed with
HFD for over 24 weeks, the HO-1
+/2 chimeras were protected from HFD-induced insulin resistance and this was associated
with reduced adipose macrophage infiltration and angiogenesis, suggesting that HO-1 affects myeloid cell migration
toward adipose tissue during obesity. In vivo and in vitro migration assays revealed that HO-1
+/2 macrophages exhibited an
impaired migration response. Chemoattractant-induced phosphorylation of p38 and focal adhesion kinase (FAK) declined
faster in HO-1
+/2 macrophages. Further experiments demonstrated that carbon monoxide and bilirubin, the byproducts
derived from heme degradation by HO-1, enhanced macrophage migration by increasing phosphorylation of p38 and FAK,
respectively. These data disclose a novel role of hematopoietic cell HO-1 in promoting adipose macrophage infiltration and
the development of insulin resistance during obesity.
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Introduction
Obesity is a major cause for insulin resistance, which is a key
risk factor of metabolic syndrome [1]. Compelling evidence has
revealed that obesity is associated with a chronic state of oxidative
stress and low-grade inflammation, which is accompanied by
increased macrophage infiltration in adipose tissues [2], [3]. The
dysregulated expression of adipokines and inflammatory cytokines
by adipocytes and infiltrating macrophages in adipose tissue
contributes to obesity-induced insulin resistance [2], [3]. It has
been shown that the infiltrating macrophages in obese adipose
tissue are derived from circulating monocytes [4]. Several
chemotactic factors, including monocytic chemotactic protein-1
(MCP-1), osteopontin, CXC motif chemokine ligand-14, and
angiopoietin-like protein 2, are upregulated in adipose tissue
during the early phase of obesity and mediate the recruitment of
monocytes to adipose tissue, and genetic ablation of these genes
ameliorates obesity-induced adipose inflammation and insulin
resistance in animals [5], [6], [7], [8]. These findings highlight the
significance of adipose macrophage infiltration in the development
of obesity-associated metabolic syndrome.
Recently, studies have shown that the resident macrophages in
lean adipose tissue express genes with characteristics of M2 or
alternatively activated macrophages [9], [10], [11]. Obesity
induces a phenotypic switch of the adipose macrophages from
M2 state to the M1 or classical activated macrophages expressing
CD11c and proinflammatory cytokines [9], [10], [11]. Depletion
of CD11c-positve cells has been shown to normalize the insulin
sensitivity in obese mice [12]. Whereas, disruption of PPAR-
gamma or PPARdelta gene in macrophages impairs M2
macrophage activation and predisposes the animals to develop
insulin resistance [13], [14], [15], [16]. These findings support the
pathophysiological significance of adipose macrophage polariza-
tion in the regulation of insulin resistance.
In addition to macrophage infiltration, adipose tissue expan-
sion during obesity is accompanied with vascular remodeling
[17], [18]. Treatment of mice with angiogenesis inhibitor
prevents the increase of white adipose mass induced by high
fat diet (HFD) and in genetic mouse model, and increases insulin
sensitivity of HFD-fed mice [19], [20]. These observations
indicate that angiogenesis is crucial for the development of
obesity and associated insulin resistance. It has been shown that
the bone marrow-derived LYVE-1(+) macrophages recruited to
the tip region of adipose tissue have an angiogenic role in the
outgrowth of adipose tissue under normal circumstances [21]. As
activated macrophages can produced multiple angiogenic factors
[17], [22], it is conceivable that HFD-induced increase of adipose
macrophages may influence the development of obesity via
influencing adipose angiogenesis.
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2Heme oxygenase-1 (HO-1) is a stress-inducible enzyme
catalyzing the oxidative degradation of heme to release free iron,
carbon monoxide (CO), and biliverdin [23]. In addition to its role
in heme catabolism, HO-1 plays important roles in various
pathophysiological states associated with cellular stress. Numerous
studies have demonstrated that biliverdin and its metabolite,
bilirubin, are antioxidants, and CO exerts a potent anti-
inflammatory effect in various disease settings [23]. Systemic
induction of HO-1 by treatment with hemin or cobalt protopor-
phyrin in ob/ob mice or Zucker rats has been shown to reduce
adiposity and improve insulin sensitivity in the diabetic animals
[24], [25], [26], suggesting the potential of HO-1 as a therapeutics
for type II diabetes. The protective effect of systemic HO-1 was
shown to be mediated by an increase in adiponectin expression,
enhanced AMP kinase activation in both adipocytes and skeletal
muscles, and suppression of adipogenesis and inflammatory
cytokine expression. Whether systemic HO-1 has an impact on
adipose macrophages in these experimental settings is not clear. A
HO-1 null mutation in macrophages has been shown to be
associated with increased levels of reactive oxygen species and
inflammatory cytokines following stimulation by oxidized low-
density lipoprotein [27]. HO-1 induction is implicated in the
polarization of macrophages toward the anti-inflammatory M2
phenotype induced by apoptotic cells [28]. Nevertheless, the effect
of HO-1 on adipose macrophage polarization and associated
inflammation during obesity has not yet been explored. On the
other hand, HO-1 induces vascular endothelial growth factor
(VEGF) in macrophages and promotes angiogenesis during wound
healing and tissue remodeling [29]. In this regard, macrophage
HO-1 may influence obesity through increasing adipose angio-
genesis. In order to explore the pathophysiological role of
macrophage HO-1 in this disease setting, we performed a bone
marrow transplantation (BMT) experiment on irradiated B6 mice
with bone marrow cells isolated from wild-type (WT) or HO-1
+/2
mice to assess the role of hematopoietic HO-1 on HFD-induced
adipose inflammation and insulin resistance in animals. Our data
showed that hematopoietic HO-1 haploinsufficiency protected
mice from obesity-induced insulin resistance by reducing adipose
macrophage infiltration and inflammation. Additional experi-
ments were also performed to reveal the underlying mechanism
involved.
Results
HFD Induces HO-1 Expression in White Adipose Tissue
To examine whether HO-1 expression is induced by HFD, we
performed Western blot analysis on various tissues isolated from
C57BL/6J mice fed a regular chow diet or a HFD for 3 months.
As shown in Fig. 1A, HO-1 expression in the spleen, lung, kidney,
and brown adipose tissue was not significantly affected by HFD
and only moderately increased in the liver. However, HO-1
expression in visceral white adipose tissue (WAT) was significantly
higher in the HFD-fed group. Further experiment revealed that
HFD-induced HO-1 expression was substantially higher in the
stromal vascular fraction (SVF) than in the adipocyte fraction
isolated from the WAT of obese mice (Fig. 1B & 1C).
Hematopoietic HO-1 Haploinsufficiency Protects Mice
from HFD-induced Insulin Resistance
Bone marrow-derived macrophages represent a significant
proportion of the cells recruited to the SVF of adipose tissue
during obesity [4]. To evaluate the effect of HO-1 in
hematopoietic cells on adipose macrophage infiltration and
insulin resistance in HFD-fed mice, we performed BMT
experiments to generate chimeric mice bearing wild-type (WT)
or HO-1
+/2 bone marrow. As the B6 strain mouse is the most
commonly used model for HFD-induced obesity, the HO-1
+/2
mice, originally on the B6/129SV mixed genetic background,
were backcrossed six generations onto the C57BL/6J genetic
background prior to be used as donors for the BMT to C57BL/
6J recipient mice. The reason for using bone marrow from HO-
1
+/2 but not HO-1
2/2 mice for experiments is two-fold. First,
HO-1 deficiency causes partial embryonic lethality [30], which is
exacerbated in C57BL/6J genetic background. Consistent with
previous report by others [31], we had not been able to obtain
any viable HO-1
2/2 pup from the HO-1
+/26HO
+/2 breeding
pairs over one year of time, which precluded us from conducting
the experiments with HO-1
2/2 mice. Second, HO-1 deficiency
is not very common in humans. Although the impact of HO-1
haploinsufficiency is less profound, study with heterozygote
knockout mice would be more relevant to human situation. To
confirm the reconstitution efficiency in chimeras, we performed
BMT using congenic donors and recipients expressing different
lymphocyte surface markers CD45.2 and CD45.1, respectively.
Flow cytometric analysis of the circulating leukocytes isolated
from the chimeric mice at 4 weeks after BMT revealed over 90%
reconstitution (Fig. 2A). To examine whether hematopoietic HO-
1 haploinsufficiency has an effect on leukocyte differentiation, the
percentages of different cell types in the circulating bloods of WT
and HO-1
+/2 chimeras were also analyzed. As shown in Fig. 2B
& 2C, there was no significant difference in the total white cell
count and the percentages of lymphocytes, granulocytes, and
monocytes between WT and HO-1
+/2 chimeric mice examined
at 4 weeks post BMT. The relative abundance of the circulating
monocyte subsets, Ly-6C
hi vs LY-6C
low, were also analyzed. As
demonstrated in Fig. S1, no significant difference was observed
between WT and HO-1
+/2 chimeras. These results indicate that
the differentiation of various blood cell types and their releases
from bone marrow were not altered in HO-1
+/2 chimeras. To
examine the effect of hematopoietic HO-1 haploinsufficiency on
HFD-induced insulin resistance, the chimeras were fed a regular
chow diet or a HFD starting 4 weeks after BMT. Blood cell
genotyping performed at 24 weeks after BMT confirmed that the
reconstitution of the donor bone marrow in the recipient B6
mice maintained at least for 6 months (Fig. S2). As shown in
Table 1, HFD feeding for 24 weeks resulted in a significant
increase in body weight in both chimeras. The food intake and
metabolic rate were similar between WT and HO-1
+/2chimeras
placed on either chow diet or HFD. However, the WT chimeras
gained ,12% more weight than the HO-1
+/2chimeras after
HFD feeding. A micro-CT scan revealed that the WAT volume
was greater in HFD-fed groups than the chow diet-fed groups
and was greater in the HFD-fed WT chimeras than in the HFD-
fed HO-1
+/2chimeras, indicating that the greater fat mass
contributes to the greater weight gain in WT chimeras. Likewise,
fasting insulin level was significantly increased in the WT
chimeras after HFD feeding, but hyperinsulinemia was less
evident in the HFD-fed HO-1
+/2chimeras. The glucose toler-
ance test (GTT) and the insulin tolerance test (ITT) revealed no
significant difference between the chow diet-fed WT and HO-1
+/
2chimeras (Fig. 3A). Whereas, when the HFD-fed chimeras were
tested, the WT chimeras showed much slower glucose clearance
and were less responsive to insulin (Fig. 3B).
Hematopoietic HO-1 Affects Macrophage Infiltration and
Inflammatory Gene Expression in Obese Adipose Tissue
Pathological assessment of the visceral WAT of these chimeras
after 36 weeks of HFD feeding revealed substantial enlargement
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and HO-1
+/2chimeras (Fig. S3A). Immunostaining experiments
performed with antibody against the macrophage surface marker,
F4/80, showed that the extent of macrophage infiltration,
characterized by a crown-like structure surrounding dead
adipocytes, was significantly higher in the WAT of the HFD-
fed WT chimeras than in the corresponding HO-1
+/2chimeras
(Fig. 3C & 3D). We also performed immunostaining with
antibody against CD31, a specific marker of endothelial cells. As
shown in Fig. 3E & 3F, the vascular density, after normalization
by the adipocyte density (Fig. S3B & S3C), in the adipose tissue
was significantly increased in HFD-fed chimeras and was much
higher in the HFD-fed WT chimeras than in the HFD-fed HO-
1
+/2chimeras. To assess the effect of the infiltrating WT and
Figure 1. Effect of HFD feeding on HO-1 expression in various tissues. Male B6 mice (8-week-old) were fed a regular chow (RC) diet or a HFD
for 12 weeks, then were sacrificed. A, HO-1 protein expression in the spleen, kidney, lung, liver, brown fat tissue (BAT), and white fat tissue (WAT) of
three mice per group examined by Western blot analysis. B, The SVF and adipocytes from the visceral fat tissue were isolated from three individual
mice of each group and subjected to Western blot analysis. C, HO-1 levels were quantified by densitometry. *P,0.05 vs the chow diet-fed group.
doi:10.1371/journal.pone.0038626.g001
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+/2 macrophages on adipose inflammation, we performed
quantitative RT-PCR to analyze inflammatory gene expression
in the SVF and adipocyte fractions of these mice. The results
showed that, in the SVF, the HFD induced high expression of
inflammatory cytokine genes, including tumor necrosis factor-a
(TNF-a), interleukin-6 (IL-6), and MCP-1 (Fig. 4A). However,
when TNF-a and IL-6 mRNA levels in the HFD-fed chimeras
were compared, there was no significant difference between these
two groups of mice, but, interestingly, MCP-1 expression was
significantly higher in the SVF of the HFD-fed HO-1
+/
2chimeras. In parallel with the higher degree of macrophage
infiltration and vascularization in the WAT of the HFD-fed WT
chimeras, levels of F4/80 and VEGF mRNAs in the SVF of this
group of mice were substantially higher than those in the
corresponding HO-1
+/2chimeras, whereas chemokine stromal
cell-derived factor (SDF-1) mRNA levels showed no substantial
difference (Fig. 4A). We also examined the levels of CD11c and
mannose receptor, which are the surface markers for M1 and
Figure 2. Generation of hematopoietic HO-1
+/2 chimeric mice. A, C57BL/6 mice (B6.SJL-Ptprc
a Pepc
b/BoyJ ) expressing CD45.1 alloantigen
(Ly5.1) on the surface of circulating leukocytes were lethally irradiated, followed by transplantation of bone marrow cells isolated from C57BL/6J mice
expressing CD45.2. After 4 weeks, whole blood were collected from chimeric mice and analyzed for the expression of CD45.2 by flow cytometry. The
blood cells isolated from un-irradiated recipient mice were used as control. Data shown is a representative of 3 mice with independent BMT. B,
C57BL/6J mice were lethally irradiated and received transplantation of bone marrow cells isolated from WT and HO-1
+/2 mice. At 4 weeks after BMT,
peripheral blood was collected and white blood cell count was determined. The number of mice in each chimeric group is five. C, The percentages of
various blood cell types were analyzed by flow cytometry. The number of mice analyzed in each group is five.
doi:10.1371/journal.pone.0038626.g002
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level of F4/80, both expression levels of CD11c and mannose
receptors were markedly increased in the SVF of the HFD-fed
chimeras. Moreover, both expression levels were significantly
higher in the SVF of the HFD-fed WT chimeras as compared to
those in the corresponding HO-1
+/2counterparts (Fig. 4A). In
the adipocyte fraction, gene expression analysis revealed that the
HFD significantly increased levels of mRNAs coding for TNF-a,
IL-6, MCP-1, and SDF-1. The increase in TNF-a mRNA was
much greater in the WT chimeras than the HO-1
+/2 chimeras,
whereas IL-6, MCP-1, and SDF-1 mRNA levels showed no
significant difference between these two groups (Fig. 4B). In
contrast, adiponectin and VEGF mRNA levels were significantly
decreased by the HFD, with no significant difference between the
two chimeras (Fig. 4B). Consistent with the mRNA expression
levels in adipocytes, the protein levels of TNF-a, IL-6 and MCP-
1 determined by ELISA were substantially higher in the WAT of
HFD-fed chimeras as compared to these of chow diet-fed
counterparts (Fig. 4C). Moreover, HFD-induced increase of
TNF-a protein expression was significantly greater in WT
chimeras than in HO-1
+/2 chimeras.
Hematopoietic HO-1 has No Effect on HFD-induced Liver
Steatosis
To assess whether hematopoietic HO-1 has an impact on liver
steatosis in obese mice, the liver triglyceride (TG) level was
determined. As shown in Fig. 5A, liver TG was significantly
increased by HFD. Nevertheless, hematopoietic HO-1 haploin-
sufficiency did not affect the increase of liver TG in HFD-fed
chimeras. This was further confirmed by the H&E staining,
which showed similar severity of liver steatosis in both HFD-fed
chimeras (Fig. 5B). Likewise, analysis of hepatic inflammatory
gene expressions did not reveal significant difference in the
expressions of F4/80, TNF-a, IL-6. and MCP-1 between HFD-
fed WT and HO-1
+/2 chimeras (Fig. 5C).
HO-1 Affects Macrophage Migration Response in vivo
and in vitro
To explore the mechanism underlying the reduced adipose
macrophage infiltration in the HFD-fed HO-1
+/2 chimeras, we
performed an in vivo migration assay in WT and HO-1
+/2 mice
by measuring LPS-induced efflux of thioglycollate-induced
macrophages from the peritoneal cavity [32]. As shown in
Fig. 6A, the numbers of F4/80-positve macrophages accumulat-
ed in the peritoneal cavities at 4 days after thioglycollate injection
were comparable in WT and HO-1
+/2 mice. Lipopolysaccharide
(LPS) treatment for 4 hr led to a substantial reduction of
macrophages in the peritoneal cavity in WT mice, whereas no
significant LPS-induced macrophage efflux was observed in HO-
1
+/2 mice. We next performed an in vitro migration assay using
peritoneal macrophages isolated from WT and HO-1
+/2 mice.
As shown in Fig. S4A, HO activity was significantly lower in
HO-1
+/2 macrophages as compared to that of WT counterparts.
Moreover, the level of reactive oxygen species (ROS) detected by
a redox-sensitve fluorescent dye was significantly higher in HO-
1
+/2 macrophages (Fig. S4B & S4C), indicating that HO-1
haploinsufficiency has an impact on the redox state of
macrophages. When the migration responses of WT and HO-
1
+/2 macrophages following VEGF or MCP-1 stimulation were
examined using the transwell migration system, the results
showed that WT macrophages exhibited better basal migration
than HO-1
+/2 macrophages and also showed better VEGF or
MCP-1-induced migration (Fig. 6B). We also performed the
migration assay using the monocytes isolated from circulating
blood. As demonstrated in Fig. S5A, the CD11b
+ Ly-6G
2
monocytes isolated from WT and HO-1
+/2 mice were over 90%
purity. Similar to peritoneal macrophages, HO-1
+/2 monocytes
exhibited significantly lower migration response to MCP-1 as
compared to WT monocytes (Fig. S5B). Western blot analysis
demonstrated that levels of the MCP-1 receptor CCR2 or the
VEGF receptor-1 Flt-1 were comparable in the WT and HO-1
+/
2 macrophages (Fig. 6C). These results indicate that HO-1
haploinsufficiency impaired the migration ability of monocytes/
macrophages.
HO-1 Modulates the Signaling Pathways Implicated in
the Migration Response
Cell migration is a complex process regulated by the activation
of various kinase signaling pathways. As HO-1 has been shown
to modulate p38 and AKT signaling in various cellular contexts
[23], we first examined whether the basal and MCP-1-induced
migration responses of macrophages from WT mice were
affected by the inhibition of p38 or/and AKT activation. As
shown in Fig. 7A, both basal and MCP-1-induced migration was
Table 1. Metabolic parameters of the WT and HO-1
+/2 chimeras fed regular chow diet or HFD.
Diet Regular chow HFD
BM genotype WT (n=9) HO-1
+/2 (n=10) WT (n=10) HO-1
+/2(n=10)
Body weight (g) 25.1060.69 25.5760.44 34.0061.54
# 30.4861.36
#1
Food intake (g/d/mouse) 2.8960.11 3.0860.08 2.3760.04
# 2.1160.03
#




3) 16016277 16206237 1197461123
# 882661386
#1
Serum cholesterol (mg/dl) 107.366.7 88.763.3 193.967.4
# 192.066.5
#
Serum triglyceride (mg/dl) 58.962.3 57.762.4 61.762.7 50.962
1
Serum glucose (mg/dl) 133.167.66 147.668.68 165.063.8
# 159.965.54
Serum insulin (ng/ml) 0.5860.16 0.6960.16 1.3060.18
# 0.8460.12
1
The number of animals in each group is indicated in parenthesis. The data are expressed as the mean 6 SEM.
#Significant difference between different diets within the same genotype.
1Significant difference between different genotypes on the same diet. p,0.05. Body weight, metabolic rate (MR), and WAT volume were measured after 24 weeks on
the diets, while serum was collected at 26 weeks.
doi:10.1371/journal.pone.0038626.t001
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pharmacological inhibitors of p38 and AKT activation, respec-
tively. To assess whether the effect of HO-1 on macrophage
migration was mediated through p38 and AKT-dependent
signaling, MCP-1-induced phosphorylation of p38 and AKT
was compared in WT and HO-1
+/2 macrophages. The results
showed that MCP-1 induced phosphorylation of p38 and AKT,
which was first evident at 5 and 30 min, respectively, then
gradually decayed (Fig. 7B & 7C). After 60 min of MCP-1
stimulation, phosphorylated p38 level in HO-1
+/2 macrophages
was much lower than that in WT macrophages, indicating that
phosphorylated p38 decayed more rapidly in HO-1
+/2 macro-
phages. Whereas, AKT phosphorylation levels at 30 min and
60 min of MCP-1 stimulation were not significantly different
between WT and HO-1
+/2 macrophages. The effect of HO-1
on FAK tyrosine phosphorylation in macrophages, one of the key
signaling events leading to actin polymerization [33], [34], was
also examined. As shown in Fig. 7B and 7C, FAK phosphor-
ylation was significantly increased at 30 min and sustained for up
to at least 60 min following MCP-1 treatment in WT macro-
phages, but no significant increase was seen in HO-1
+/2
macrophages. When WT and HO-1
+/2 macrophages were
subjected to VEGF treatment, similar results were obtained
(Fig. 7D & 7E).
Figure 3. HO-1 haploinsufficiency in hematopoietic cells protects mice from HFD-induced insulin resistance. A and B, Chimeric mice
with transplanted WT or HO-1
+/2 bone marrow were fed a regular chow (RC) diet (A) or a HFD (B), then a glucose tolerance test (GTT) and an insulin
tolerance test (ITT) were performed at week 28. The number of animals in each group was nine or ten. *P,0.05 vs WT chimeras. C and E, The animals
were sacrificed after 36 weeks on the different diets and the visceral fat tissue immunostained using antibody against F4/80 (C) or CD31(E) as
described in the Materials and Methods. D, F4/80-positive macrophages were quantified as the percentage of adipocytes surrounded by a crown-like
structure in the total adipocytes. F, Normalized vascular density was quantified as the CD31-positive area divided by adipocyte density per field.
*P,0.05 vs the chow diet-fed group of the same genotype;
{P,0.05 vs HFD-fed WT group.
doi:10.1371/journal.pone.0038626.g003
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38626Figure 4. Inflammatory gene expression profiles of SVF and adipocytes from WT and HO-1
+/2chimeras. Chimeric mice transplanted
with WT or HO-1
+/2 bone marrow were fed a regular chow (RC) diet or a HFD for 36 weeks, then the animals were sacrificed, the visceral adipose
tissues collected, and the SVF and adipocytes isolated as described in Materials s and Methods. The expressions of the indicated genes in the SVF (A)
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Modulating p38 and FAK Phosphorylation
CO has been shown to mediate the anti-inflammatory effect of
HO-1 on macrophages [35]. To explore whether CO had an
effect on macrophage migration, WT macrophages were exposed
to the CO-releasing compound, tricarbonyldichlororuthenium (II)
dimer (CORM-2) [36]. As shown in Fig. 8A, CORM-2 promoted
the basal migration response in a dose-dependent manner, with
the maximal effect at 10 mM, whereas inactivated CORM-2 had
no effect. MCP-1-induced migration was also enhanced by
treatment of the macrophages with CORM-2. These results
suggest that CO derived from heme degradation mediates, at least
in part, the effect of HO-1 on macrophage migration. A further
experiment demonstrated that CORM-2 treatment of macro-
phages induced a substantial increase in p38 phosphorylation, but
not AKT phosphorylation (Fig. 8B & 8C). Treatment of
macrophages with SB203580 to inhibit p38 activation also
significantly suppressed CORM-2-induced macrophage migration
(Fig. 8D), support a role of p38 in the CO-mediated effect. We
next examined whether bilirubin, an antioxidant produced during
the degradation of heme by HO-1, had an effect on macrophage
migration. As shown in Fig. 9A, 10 mM bilirubin significantly
increased basal migration, whereas a higher concentration
(20 mM) had less effect. Treatment with 10 mM bilirubin also
enhanced MCP-1-induced migration (Fig. 9A). Since ROS has
been shown to downregulate FAK activation [37], we examined
whether bilirubin affected FAK phosphorylation. As shown in
Fig. 9B & 9C, treatment of macrophages with 10 mM bilirubin
caused a transient increase in FAK phosphorylation, which was
evident as early as 5 min after treatment.
Discussion
The present study showed that HO-1 was highly induced in the
WAT of HFD-fed mice. A similar observation has been reported
in ob/ob mice [38]. Notably, HO-1 expression in other tissues
examined was either not significantly affected or only modestly
upregulated. Earlier studies by others have shown that aortic HO-
1 expression was significantly reduced in ob/ob mice and Zucker
fatty rats [24], [25], indicating that HO-1 is differentially regulated
in different tissues in obese mice. Interestingly, HFD-induced
adipose HO-1 overexpression was greatest in the SVF, which
contains substantial numbers of infiltrating macrophages. Since
HO-1 exerts potent anti-inflammatory and proangiogenic effects
on macrophages, we were interested in exploring how its
expression in hematopoietic cells affected adipose inflammation
and insulin resistance during obesity. To this end, we generated
chimeras reconstituted with WT or HO-1
+/2 bone marrow and
fed these mice with HFD for over 6 months. To our surprise,
HFD-feeding resulted in ,12% greater weight gain and higher
adiposity in the WT chimeras than the HO-1
+/2 chimeras even
the food intakes of both chimeras were similar The metabolic rates
determined in HFD-fed WT and HO-1
+/2 chimeras also showed
no significant difference. We speculate that the lean body mass,
which makes a great contribution to the total energy expenditure
[39], was the primary determinant of the metabolic rate in both
chimeras. Nevertheless, further study is required to clarify the
issue. It was found that HFD-fed WT chimeras developed
and adipocytes (B) were then quantified by real time RT-PCR. The expression level of 36B4 gene was used as an internal control for normalization. The
number of animals in each group was four to seven. P,0.05 vs the chow diet-fed group of the same genotype;
{P,0.05 vs the HFD-fed WT group. C,
The protein levels of proinflammatory cytokines in extracts of adipose tissues were determined by ELISA as described in Materials and Methods.
P,0.05 vs the chow diet-fed group of the same genotype;
{P,0.05 vs the HFD-fed WT group.
doi:10.1371/journal.pone.0038626.g004
Figure 5. Hematopoietic HO-1 haploinsufficiency has no effect
on HFD-induced liver steatosis. Chimeric mice harboring WT or HO-
1
+/2 bone marrow were subjected to chow diet or HFD for 36 weeks. A,
Liver tissues were collected and the TG contents were determined. The
number of mice in each group is nine to ten. B, The representative
images of the H & E stain. C, The expression levels of indicated genes in
the livers of HFD-fed WT and HO-1
+/2 chimeras. The number of animals
in each group is five.
doi:10.1371/journal.pone.0038626.g005
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differences in these clinical parameters of WT and HO-1
+/2
chimeras were considered modest, the disease manifestations in
the HFD-fed mice correlated with the extent of adipose
macrophage infiltration as shown immunohistochemically. The
number of infiltrating macrophages was much higher in the
adipose tissue of obese WT chimeras than in their HO-1
+/2
counterparts, indicating that more WT macrophages were
recruited into the adipose tissue of mice during obesity.
Interestingly, the vascular density, detected by immunostaining
with antibody against endothelial CD31, was also significantly
greater in HFD-fed WT chimeras than HO-1
+/2 chimeras. Since
adipose tissue expansion is dependent on angiogenesis [17], the
increased vascularization probably contributes to the greater
adiposity seen in the HFD-fed WT chimeras. Although HO-1 has
an anti-inflammatory action, we speculated that the adipose
inflammation was still exacerbated by the recruitment of more
macrophages in the WT chimeras than in the HO-1
+/2 chimeras.
To further assess the impacts of recruited WT and HO-1
+/2
macrophages on the adipose inflammatory response, we analyzed
inflammatory gene expression in the SVF and adipocyte fraction
isolated from the adipose tissues of HFD-fed WT and HO-1
+/2
chimeras. Correlating with the higher macrophage content of the
adipose tissue in HFD-fed WT chimeras, F4/80 mRNA level was
significantly higher in the SVF from this group of mice, as was
VEGF mRNA level. As HO-1 has been shown to induce VEGF
expression, the infiltrating WT macrophages might contribute to
the higher VEGF expression in the SVF of the HFD-fed WT
chimeras, which in turn enhanced the adipose angiogenesis and fat
mass expansion in this group of animals. Moreover, the higher
content of infiltrating WT macrophages accounted for the high
levels of TNF-a and IL-6 mRNAs detected in the SVF of the
HFD-fed WT chimeras, even though HO-1 is known to suppress
inflammatory cytokine expression. However, MCP-1 mRNA level
was much higher in the SVF from the HO-1
+/2 chimeras. A
previous study has shown that MCP-1 was robustly induced in
circulating leukocytes of HO-1
2/2 mice even in the unstressed
condition [40], indicating that MCP-1 expression is most sensitive
to the regulation by HO-1. Although fewer HO-1
+/2 macro-
phages were recruited to the adipose tissue, it appears that the total
level of MCP-1 expressed by HO-1
+/2 macrophages still
surpassed the level expressed by the high content of WT
macrophages in the adipose tissue of WT chimeras. We performed
additional experiments to examine whether hematopoietic HO-1
has an effect on adipose macrophage polarization during obesity.
The gene expression analysis revealed that the relative expression
Figure 6. Hematopoietic HO-1 haploinsufficiency impairs macrophage migration. A, Thioglycollate-induced peritoneal macrophages from
WT and HO-1
+/2 mice were isolated and quantified 4 h after the mice received an intraperitoneal injection of PBS or LPS (1.25 mg). The number of
animals was six for each group of the WT mice and nine for each group of the HO-1
+/2 mice. *P,0.05 vs the PBS-treated group of the same
genotype. B, Peritoneal macrophages isolated from WT and HO-1
+/2 mice were tested in an in vitro transwell migration assay. The macrophages
isolated from each individual mouse were tested for their migration response to 10 ng/ml of MCP-1 or VEGF as indicated; Con are controls. The
number of animals in each group was six. *P,0.05 vs the WT control macrophages;
{P,0.05 vs the HO-1
+/2 control macrophages;
#P,0.05 vs WT
macrophages receiving the same treatment. C, HO-1, CCR2, and Flt-1 protein levels in WT and HO-1
+/2 macrophages examined by Western blot
analysis.
doi:10.1371/journal.pone.0038626.g006
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38626Figure 7. HO-1 influences chemoattractant-induced signaling. A, WT peritoneal macrophages were tested in an MCP-1 (10 ng/ml)-induced
transwell migration assay in the absence or presence of SB203580 (20 mM; p38i)) or Akt inhibitor VIII (10 mM; AKTi). The data are the mean 6 SEM for
three independent experiments. * and
{P,0.05 vs the corresponding control group;
#P,0.05 vs the MCP-treated group. B-E, Peritoneal macrophages
isolated from WT and HO-1
+/2 mice were stimulated with 10 ng/ml of MCP-1 (B &C) or VEGF (D &E) for the indicated times, then the phosphorylation
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38626status of the indicated kinases was examined by Western blot analysis (B & D) and levels of phospho-p38, phospho-AKt, and phospho-FAK quantified
by densitometry (C & E). The data were presented as the normalized intensity relative to that of the zero-time point WT control group, which was set
to 1. The results shown are the mean 6 SEM for three to four independent experiments. * P,0.05 vs WT macrophages.
doi:10.1371/journal.pone.0038626.g007
Figure 8. CO promotes macrophage migration by modulating p38 signaling. A, Peritoneal macrophages from WT mice were tested in a
transwell migration assay without or with MCP-1 (10 ng/ml). Macrophages in the upper chamber were concurrently treated without or with the
indicated concentrations of CORM-2 or iCORM-2. The data are the mean 6 SEM for three independent experiments. * P,0.05 vs the untreated
control.;
{P,0.05 vs the MCP-1-treated cells. B, WT macrophages were treated with 10 mM iCORM-2 or CORM-2 for the indicated time, then
phosphorylation of p38 or AKT was examined by Western blot analysis. C, The levels of phospho-p38 and phospho-AKT were quantified by
densitometry. The data were presented as the normalized intensity relative to that of DMSO-treated group, which was set to 1. The results shown are
the mean 6 SEM for three independent experiments. * P,0.05 vs iCORM-2-trerated cells. D, Transwell migration assay performed using macrophages
treated without or with 10 mM CORM-2 in the absence or presence of SB203580 (20 mM). The data shown are the mean 6 SEM for four independent
experiments. * P,0.05 vs the untreated control.
{P,0.05 vs CORM-2 treatment. The relative migration is the migration of the treated group expressed
as a percentage of that of the control group.
doi:10.1371/journal.pone.0038626.g008
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the SVF fractions of HFD-fed WT and HO-1
+/2 chimeras,
indicating that WT macrophages did not exhibit a preference
toward M2 polarization. Although a previous study has shown that
HO-1 is implicated in apoptotic cell-induced M2 macrophage
polarization [28], different mechanism may underlie macrophage
polarization in the obese adipose tissue. Experiments were then
performed to assess the inflammatory gene expression in the
adipocyte fractions of HFD-fed chimeras. The results showed that
adipocyte TNF-a mRNA level was much higher in the WT
chimeras than in the HO-1
+/2 chimeras, supporting the close link
between increased macrophage infiltration and adipocyte inflam-
Figure 9. Bilirubin promotes macrophage migration by enhancing FAK phosphorylation. A, WT peritoneal macrophages were tested in a
transwell migration assay without or with MCP-1 (10 ng/ml) and the macrophages in the upper chamber were concurrently treated without or with
bilirubin at the indicated concentration. The data are the mean 6 SEM for four independent experiments. * P,0.05 vs the untreated control.
{P,0.05 vs MCP-1 treatment. B, WT macrophages were treated without or with 10 mM bilirubin for the indicated time, then phosphorylation of FAK
was examined by Western blot analysis. C, The levels of phsopho-FAK were quantified by densitometry. The data were presented as the normalized
intensity relative to that of the zero-time point control group, which was set to 1. The results shown are the mean 6 SEM for three independent
experiments. * P,0.05 vs the untreated control.
doi:10.1371/journal.pone.0038626.g009
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difference in levels of mRNAs for other cytokines, such as IL-6
and MCP-1, between the WT and HO-1
+/2 chimeras. The
reason for this phenomenon is not clear. Since other immune cells
are also implicated in obesity-induced adipose inflammation [41],
an effect of HO-1 on other immune cells and their involvement in
regulating the adipocyte inflammatory response cannot be
excluded. Future study using myeloid-specific HO-1 deficient
mice will be required to clarify the issue. Nevertheless,, the results
from the present study clearly demonstrated that HO-1 haploin-
sufficiency in hematopoietic cells protected mice from HFD-
induced insulin resistance, which was associated with decreased
adipose macrophage infiltration and inflammation.
To further investigate the possibility that HO-1 impacts
monocyte/macrophage migration to adipose tissue, we first
performed the macrophage efflux assay in WT and HO-1
+/2
mice with thioglycollate-induced peritonitis. The numbers of
peritoneal macrophages examined at 4 days after thioglycollate
injection in WT and HO-1
+/2 mice were comparable. It has been
shown that the extent of macrophage accumulation in the
inflammatory site in the late phase is influenced by the emigration
of macrophages to lymphatics [42] We speculated that HO-1
haploinsufficiency has similar effect on both migration and
emigration of macrophages in the early and late phases of
peritonitis, resulting in the accumulation of macrophages in
peritoneum of HO-1
+/2 mice to a similar extent as that in WT
mice at 4 days after thioglycollate injection. However, a
subsequent treatment of LPS induced a significant efflux of
peritoneal macrophages within a short period of time in WT but
not HO-1
+/2 mice. The impaired migration response of HO-1
+/2
macrophages was confirmed in the in vitro transwell migration
assay. Similar result was observed in the migration assay with
circulating monocytes isolated from WT and HO-1
+/2 mice,
indicating that HO-1 exerts same effect on the migration responses
of monocytes and macrophages. Since peritoneal macrophages are
easier to obtain in large quantities, we used peritoneal macro-
phages for the subsequent mechanistic studies. We compared
cellular signaling pathways in WT and HO-1
+/2 macrophages
following stimulation with MCP-1, which induces monocyte
migration via the p38- and AKT–dependent pathways [43],
[44]. The results showed that MCP-1 treatment resulted in a
rapid, but transient, increase in p38 phosphorylation in both WT
and HO-1
+/2 macrophages and that phosphorylated p38 levels
declined more rapidly in HO-1
+/2 macrophages. AKT phos-
phorylation was also induced by MCP-1, but the levels were not
statistically different between WT and HO-1
+/2 macrophages.
Similar results were observed when VEGF was used as the
chemoattractant. As p38-mediated signaling is implicated in
chemoattractant-induced macrophage migration, we reasoned
that the slower decay of p38 phosphorylation observed in WT
macrophages contributed to their greater motility. Subsequent
experiment demonstrated that CO, which has been shown to
modulate p38 activation in macrophages [35], significantly
enhanced both basal cell mobility and MCP-1-induced migration,
supporting that CO mediates, at least in part, the effect of HO-1
on macrophage migration. CO has also been shown to induce the
migration of endothelial progenitor cells [45]. Nevertheless, a
recent study demonstrated that CO decreased platelet-derived
growth factor-induced smooth muscle cell migration [46]. The
effect of CO on cell motility appears to be cell type specific. We
also examined the effect of bilirubin, an antioxidant produced
during heme degradation by HO-1, on macrophage migration. As
CO donor, bilirubin significantly enhanced macrophage migration
in both the absence and the presence of MCP-1. This finding is
consistent with previous reports showing that macrophage
function, including motility, is significantly improved by antiox-
idants [47], [48]. We then showed that bilirubin treatment led to a
transient increase in FAK phosphorylation, which is vital for the
regulation of cell mobility. These data support the role of bilirubin
in mediating part of the effect of HO-1 on macrophage migration.
In summary, the present study identified a novel function of
HO-1 in macrophages. Although it is regarded as an anti-
inflammatory enzyme which suppresses the production of
proinflammatory cytokines in macrophages, HO-1 can impact
the migration response of macrophages through modulating p38
and FAK activations. HO-1 expression in hematopoietic cells
promotes the migration of macrophages toward the adipose tissue
during obesity and exacerbates the development of metabolic
disease. This finding is contradictory to the previous reports
showing that systemic induction of HO-1 in diabetic animals
reduced adiposity and improved insulin sensitivity [24], [25], [26].
It is speculated that the salutary effects of HO-1 on adipocytes and
skeletal muscles as demonstrated in these earlier studies might
overpower the effect of HO-1 on macrophage migration toward
obese adipose tissue in their experimental settings. Moreover, the
possibility that the down regulation of chemokine expression
induced by HO-1 in adipocytes might restrict the adipose
macrophages recruitment can not be excluded. Despite these
studies supporting the protective effect of systemic HO-1 induction
on obesity-induced insulin resistance, there was a report showing
that the endogenous HO-derived CO was increased and promoted
hypertension and endothelial dysfunction in obese Zucker rats
[49]. In this regard, the regimen to increase HO-1 expression does
not seem to be a superior therapeutics for metabolic diseases as
suggested by previous studies [24], [25], [26]. It is apparent that
future studies with cell- or tissue-specific HO-1 knockout or
transgenic mice are required to delineate more precisely the




All experimental procedures with animals were approved by the
Institutional Animal Care and Utilization Committee of the
Academia Sinica, Taiwan (Protocol #: RMiIBMCL2008070).
Animals
HO-1
+/2 mice, originally on the B6/129SV mixed genetic
background, were backcrossed six generations onto the C57BL/6J
genetic background. To generate B6 chimeric mice reconstituted
with wild type (WT) or HO-1
+/2 bone marrow, we performed
BMT as described previously [50]. Briefly, bone marrow cells were
obtained by blushing the femurs and tibias of WT or HO-1
+/2
mice with PBS. Cell suspension was filtered through a 70 mm cell
strainer and the mononuclear cells were isolated by Histopaque-
1083 (Sigma) density gradient centrifugation. C57BL/6J recipient
mice (male, 6 weeks) were lethally irradiated by 9 Gy, followed by
receiving an i.v. infusion of the bone marrow-derived mononu-
clear cells (2610
6 cells/mouse) isolated from WT or HO-1
+/2
mice. To assess the BMT efficiency, a substrain of C57BL/6 mice
(B6.SJL-Ptprc
a Pepc
b/BoyJ ) expressing CD45.1 alloantigen (Ly5.1)
on the surface of circulating leukocytes were used as recipients and
C57BL/6J mice expressing CD45.2 (Ly5.2) as donors. Four weeks
after BMT, the circulating leukocytes were collected from the
chimeric mice and the expressions of CD5.2 and CD5.1 were
examined to determine the percentage of chimerism. To induce
obesity in chimeric mice, at 4 weeks after BMT animals were fed
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Diets) for the indicated period of time. All mice were kept on a
12 h light-dark cycle and allowed free access to food and water.
Body weight and serum glucose were measured every other week.
The resting metabolic rate was measured using a metabolic
respiratory system (Buxco). White adipose tissue volume was
measured using the SkyScan 1076 micro-CT system. The serum
insulin concentration was determined using a mouse insulin
ELISA kit (Millipore). Serum cholesterol and TG concentrations
were measured using a FUJI DRI-CHEM clinical chemistry
analyzer. To perform the GTT and ITT, the animals were fasted
for 6 h, then injected intraperitoneally with glucose (1 g/kg body
weight) or insulin (0.7 U/kg), respectively.
Isolation of Genomic DNA and Genotyping
Mouse tail snip (0.5 cm) or mouse whole blood (100 ml) was
incubated with 700 ml of lysis buffer containing 50 mM Tris-HCl
pH 8.0, 100 mM EDTA, 0.5% SDS and 360 mg proteinase K at
55uC for 18 h. Samples were then mixed with 700 ml of phenol/
chloroform/isoamyl alcohol (25:24:1 v/v), vortexed for 3 min at
room temperature and centrifuged at 15,500 xg for 10 min at
4uC. The upper layer was transferred to a new tube, mixed with
equal volume of chloroform/isoamyl alcohol (24:1 v/v) and
vortexed for 3 min at room temperature. Then the samples were
centrifuged again, and the upper layer was mixed with equal
volume of isopropanol. After gently mixing, the genomic DNA was
pelleted by centrifugation at 15,500 xg for 10 min at 4uC, washed
once with 75% alcohol, air dried, and resuspended in 100 ml
ddH2O. Genotyping PCR was performed by using 50 ng genomic
DNA, 62.5 pmole primer, 10 nmole dNTPs and 2.5 U FastStart
Taq DNA polymerase (Roche). The primer pairs used were wild
type allele (59-GGTGACAGAAGAGGCTAAG-39 and 59-
CTGTAACTCCACCTCCAAC-39) and mutated allele (59-
TCTTGACGAGTTCTTCTGAG-39 and 59-ACGAAGT-
GACGCCATCTGT-39). The PCR condition was 30 cycles of
94uC 30 sec, 58uC 30 sec, and 72uC 30 sec. The PCR product
was 456 bp for wild type allele and 400 bp for mutated allele.
HO Activity Measurement
Peritoneal macrophages were washed twice with PBS and
centrifuged at 115 xg for 5 min at 4uC. The cell pellet was
resuspended in 0.1 M K3PO4 pH 7.4 containing 1 mM EDTA
and 0.5 mM PMSF. After sonication, the cell homogenate was
centrifuged at 15,500 xg for 10 min at 4uC. The protein
concentration of supernatant was determined and 1 mg of proteins
was added to 0.1 M K3PO4 pH 7.4 containing 1.5 mg of rat liver
cytosol, 50 mM hemin, 1 mM NADPH, 2 mM glucose-6-phos-
phate and 0.3 units of glucose-6-phosphate dehydrogenase. The
mixture was incubated in the dark for 1 h at 37uC. Bilirubin was
then extracted with 0.5 ml chloroform and quantified by the




5 peritoneal macrophages were washed twice with Hank’s
Balanced Salt Solution (HBSS) and centrifuged at 115 xg for
5 min at room temperature. The cell pellet was resuspended in
0.5 ml HBSS containing 10 mM 5-(and-6)-chloromethyl-2,7-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA) and incubated at 37uC for 1 h in dark. Cells were
then washed once with HBSS and returned to prewarmed serum
free RPMI 1640 medium containing 0.5% BSA for 30 min at
37uC. After incubation, macrophages were washed once with
PBS/2% FBS and subjected to immunostaining with APC-
conjugated anti-F4/80 antibody for 30 min at 4uC. Subsequent-
ly, cells were washed twice with PBS/2% FBS and the intensity of
CM-H2DCFDA fluorescence in F4/80-positve cells was deter-
mined by BD
TM LSR II flow cytometer (Becton Dickinson, San
Joes, CA, USA) and data analyzed with FlowJo 7.5.5 flow
cytometry analysis software.
Isolation of Peripheral Blood Leukocytes
Peripheral blood was obtained from the tail vein and collected
into EDTA-containing tubes. After a gentle mixing, the white
blood cell count was determined by CELL-DYN 3700 (Abbott
Park, Illinois, USA). Subsequently, whole blood was subjected to
red blood cell lysis in ammonium chloride solution (BD Pharm
Lyse
TM) for 5 min at room temperature. The cells were washed
once with phosphate-buffered saline (PBS) containing 2% fetal
bovine serum (FBS) and centrifuged at 300 xg for 5 min at 4uC.
Cell pellet was then resuspended in PBS containing 2% FBS and
analyzed by flow cytometry.
Isolation of Peripheral Blood Monocytes
Peripheral blood was subjected to red blood cell lysis in
ammonium chloride solution (BD Pharm Lyse
TM) for 5 min at
room temperature. Cells were washed once with PBS containing
2% FBS and centrifuged at 300 xg for 5 min at 4uC. The cell
pellet was resuspended in PBS containing 2% FBS and
monocytes were enriched using the EasySep mouse monocyte
enrichment kit (Stemcell Tech) following the manufacturer’s
instructions with modifications. Briefly, 5610
6 white blood cells
isolated from each mouse were resuspended in 50 ml of PBS/2%
FBS and incubated with 2.5 ml normal rat serum and 2.5 ml
monocyte enrichment cocktail in a 0.5 ml centrifuge tube at 4uC
for 15 min. Cells were then washed once with PBS/2% FBS and
centrifuged at 300 xg for 5 min at 4uC. The cell pellet was
resuspended in 50 ml of PBS/2% FBS and incubated with 3 ml
biotin selection cocktail for 15 min. Subsequently, cells were
mixed with 7.5 ml of magnetic particles for 10 min and the
centrifuge tube was placed into the magnet for 5 min. The
enriched monocytes in the supernatant were then transferred to a
new tube and ready for use.
FACS Analysis
2610
5 cells were incubated with 1 mg Fc receptor block
(eBioscience) in PBS/2% FBS for 15 min at 4uC, followed by
incubation with 0.4 mg of fluorochrome-conjugated primary
antibodies for additional 30 min at 4uC. Cells were then washed
twice with PBS/2% FBS and centrifuged at 300 xg for 5 min at
4uC. Cell pellet was resuspended in PBS/2% FBS and incubated
with 0.05 mg 7-Amino-Actinomycin D (7-AAD, BD Pharmin-
gen
TM) for 10 min at 4uC for dead cell exclusion. Subsequently,
cells were analyzed by BD
TM LSR II flow cytometer (Becton
Dickinson, San Joes, CA, USA) and data were acquired and
analyzed using FlowJo 7.5.5 flow cytometry analysis software.
Fluorescein isothiocyanate(FITC) -conjugated anti-F4/80 anti-
body was used for the analysis of F4/80 expression in
macrophages. To determine the percentage of chimerism,
peripheral blood leukocytes isolated from un-irradiated CD45.1
recipients and chimeric mice were stained with Alexa FluorH 700-
conjugated anti-CD45.2 antibody. Donor specific CD45.2 fluo-
rescence emission was plotted with histogram. To compare the
leukocyte cell populations of chimeric mice, peripheral blood
leukocytes isolated from WT and HO-1
+/2 chimeras were stained
with Allophycocyanin(APC)-conjugated anti-CD11b antibody,
Phycoerythrin(PE)-conjugated anti-Ly-6G antibody, APC-eFluorH
780-conjugated anti-CD3 antibody, PE-Cy7-conjugated anti-
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identified as CD11b
+Ly-6G
2 cells Granulocytes were identified as
Ly-6G
+ cells. T lymphocytes were identified as CD3
+CD19
2 cells.
B lymphocytes were identified as CD3
2CD19
+ cells. Within the







low subsets by APC-
conjugated anti-Ly-6C antibody staining.
Isolation of the SVF and Adipocytes
Mouse visceral adipose tissue was isolated, minced into fine
pieces, and placed in Dulbecco’s Modified Eagle’s Medium
containing 5% FBS. After centrifugation at 5006g for 5 min to
pellet erythrocytes and other blood cells, the tissue suspension was
incubated with collagenase (2 mg/ml; Sigma-Aldrich) in PBS
containing 1 mM CaCl2, 0.5% bovine serum albumin, and 5 mM
glucose at 37uC for 30 min with gentle shaking (150 rpm), then
filtered through a 100 mm nylon mesh filter and centrifuged at
300 x g for 5 min at room temperature. The floating adipocytes
and the pellet (SVF) were harvested, washed twice with PBS, and
stored at 280uC.
Measurement of Hepatic TG Content
Liver tissue (0.2 g) was homogenized in 4 ml chloroform/
methanol (2:1, vol/vol), followed by addition of 0.8 ml of 50 mM
NaCl. Samples were vortexed and centrifuged at 7206g for 5 min.
The sample (50 ml) from the organic layer was dried and re-
dissolved in 20 ml of isopropanol. TG concentration was measured
using TG assay kit (Cayman). All values of tissue TG content were
normalized by liver weight.
Real-time Quantitative PCR
Total RNAs were isolated using TRIzol reagent (Invitrogen).
Reverse transcription was performed using 2 mg of total RNA,
random primers, and Superscript III reverse transcriptase
(Invitrogen). Real-time PCR was performed using a LightCyclerH
FastStart DNA MasterPLUS SYBR Green I kit (Roche Applied
Science) on a LightCyclerH Carousel-Based System (Roche
Applied Science). 36B4 was used as an internal control. The
primer pairs were TNFa (59- AGACCCTCACACTCAGA-39 and
59- CCTTGTCCCTTGAAGAGAAC-39), IL-6 (59-GAGGA-




and 59-TTACTTGTTTAAAGCTTTCTC-39), MCP-1 (59-
CTTCTGGGCCTGCTGTTCA -39 and 59-CCAGCCTACT-
CATTGGGATCA-39), adiponectin (59-GCAGAGATG GCAC-
TCCTGGA-39 and 59-CCCTTCAGCTCCTGTCATTCC-39),
F4/80 (59-TTTCCTCGCCTGCTTCTTC-39 and 59-CCCCG-
TCTCTGTATTCAACC -39), and 36B4 (59-CCCACTTACT-
GAAAAGG-39 and 59-GGCGGGATTAGTCGAA-39). CD11c
(59-GAGAGCCCAGACGAAGACAG-39 and 59-CCATTTGC-
TTCCTCCAACAT-39), Mannose receptor (59-GCAAATG-
GAGCC GTCTGTGC-39 and 59-CTCGTGGATCTCCGTGA-
CAC-39).
ELISA
Mouse epididymal adipose tissue was homogenized in lysis
buffer containing 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1%
NP-40, 1 mM CaCl2, 1 mM MgCl2, 1 mM PMSF, 10% glycerol
and a protease inhibitor mixture (Calbiochem). After 10 min
incubation on ice, tissue homogenates were centrifuged at
15500 xg for 10 min at 4uC. The supernatant was removed and
the protein concentration was determined. One hundred mgo f
tissue lysates were used for the determination of TNF-a, IL-6 and
MCP-1 protein contents using the indicated mouse ELISA kits
(R&D Systems). Data were represented as the amount of cytokine
per 100 mg tissue lysates.
Immunohistochemistry
Adipose tissue sections (5 mm) were pretreated with 3% H2O2
for 10 min at room temperature to block endogenous peroxi-
dase activity. After incubation with 5% normal goat serum for
30 min, sections were incubated with anti-F4/80 antibody
(1:300 dilution; Serotec) in PBS containing 1% normal goat
serum for 1 h at 37uC, followed by 3 washes with PBS.
Chromogenic detection of antigen was performed using an
EnvisionTM Detection system (Dako) coupled with horseradish
peroxidase/diaminobenzidine. The extent of macrophage infil-
tration was calculated as the percentage of adipocytes sur-
rounded by a F4/80-positive crown-like structure in the total
adipocytes in each field. For immunostaining of the vasculature,
sections were incubated with 20 mg/ml of proteinase K (Sigma-
Aldrich) at room temperature for 5 min. After a PBS wash, the
sections were blocked with 5% normal goat serum, followed by
incubation overnight at 4uC with antibody against CD31 (1:100
d i l u t i o n ;B DP h a r m i n g e n ) .A f t e r3P B Sw a s h e s ,t h es e c t i o n s
were incubated with FITC-conjugated secondary antibody
(1:200 dilution; Invitrogen) at room temperature for 1 h in the
d a r k ,f o l l o w e db yw a s h i n g ,a n de x a m i n e db yf l u o r e s c e n c e
microscopy. Vascular density was calculated as described
previously [51]. Briefly, the CD31 immunofluorescence images
were taken from 4 different fields per section under a
fluorescence microscope (6200 magnification). MetaMorph
image analysis software (Molecular Devices) was used for image
analysis. The CD31
+ area in each field was calculated as
[(CD31
+ signal – background (FITC-goat anti-rat IgG))/total
pixels]60.6183 mm
2 (the total real area under 2006 magnifi-




2). The normalized vascular density was
calculated by dividing the CD31
+ area with the total number
of adipocytes per area. The adipocyte density was calculated by




Tissues and cells were homogenized and lysed in ice-cold
RIPA buffer consisting of 50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM
EDTA, 1 mM PMSF, and protease and phosphatase inhibitor
cocktails (Calbiochem). Tissue and cell lysates were centrifuged
at 15,5006gf o r1 5m i na t4 uC, the supernatant collected, and
the protein concentration determined by the Bradford method
(Bio-Rad). The protein samples were then separated by
electrophoresis in 10% SDS-polyacrylamide gels and transferred
to Immobilon-P Membrane (Millipore). After blocking with 5%
skim milk in Tris-buffered saline (TBS) containing 0.1% Tween
20 (TBST), the membranes were incubated with rabbit
antibodies against HO-1 [52], CCR2 (Abcam), Flt-1 (Abcam),
GAPDH (Santa Cruz), phospho-AKT (Ser473), phospho-p38
(Thr180/Tyr182), phospho-FAK (Tyr397) (Cell Signaling), and -
AKT, p38, or FAK (all from Cell Signaling) in TBST containing
1% skim milk for 2 h at room temperature or 16 h at 4uC, then,
after 3 washes with TBST, were incubated with horseradish
peroxidase-conjugated secondary antibodies in TBST containing
5% skim milk. Bound antibody was then detected using the
enhanced chemiluminescence system. For immunoblot quantifi-
cation, the X-film was scanned by ScanMaker 8700 (MICRO-
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MetaMorph image analysis software. The band intensity of
target protein was normalized by dividing its intensity value with
the value of the internal control protein band in the same lane of
the blot. Data were presented as the normalized intensity relative
to the control group in each respective experiment.
Mouse Peritoneal Macrophages
Mice were injected intraperitoneally with 3 ml of 3% thiogly-
collate After 4 days, peritoneal macrophages were isolated by
washing the peritoneal cavity with RPMI 1640 medium contain-
ing 0.5% BSA. Cells were then plated on cell culture plate. After
4 h incubation, the non-adherent cells were removed by washing
with culture medium and the adherent cells used as peritoneal
macrophages, which were serum-deprived for 24 h prior to
stimulation with various agents. For experiments using inactivated
CORM-2, CORM-2 (Sigma-Aldrich) was incubated overnight at
37uC in serum-free RPMI 1640 medium containing 0.5% BSA
prior to use.
In vivo Migration Assay
The WT and HO-1
+/2 mice received an intraperitoneal
injection of 1 ml of 4% thioglycollate, then, 4 days later, were
injected intraperitoneally with 250 ml of PBS or LPS (5 mg/ml).
Four hours later, the peritoneal cells were harvested and the
number of macrophages quantified by flow cytometry using FITC-
conjugated anti-F4/80 antibody.
In vitro Migration Assay
Cell migration was assessed using a 24-well Transwell with a
pore size of 5 mm (Corning). 1610
5 peritoneal macrophages
suspended in serum-free RPMI 1640 medium containing 0.5%
BSA were added to the upper chambers and the lower chambers
were filled with culture medium alone or containing the indicated
chemoattractant. After 18 h incubation, cells that had migrated to
the lower surface of the membrane were fixed with 4%
paraformaldehyde for 10 min, stained with Giemsa for 2 h, and
counted under a microscope.
Statistical Analysis
Data are expressed as the mean 6 SEM for at least three
independent experiments. Student’s t test was used for statistical
comparisons between two groups of data and one-way ANOVA
was used for more than two groups. A P value ,0.05 was
considered statistically significant.
Supporting Information
Figure S1 Flow cytometric analysis of circulating mono-
cytes from WT and HO-1
+/2 chimeras. C57BL/6J mice
were lethally irradiated and received transplantation of bone
marrow cells isolated from WT and HO-1
+/2 mice. At 4 weeks








cytes were analyzed by flow cytometry. The number of mice in
each chimeric group is five.
(TIF)
Figure S2 Genotype analysis of blood cells isolated
from WT and HO-1
+/2 chimeras. C57BL/6J mice were
lethally irradiated, followed by BMT with hematopoietic stem cells
isolated from WT and HO-1
+/2 mice. At 24 weeks after BMT,
genomic DNA was isolated from the peripheral blood and
analyzed by PCR for WT allele (456 bp) and mutant allele
(400 bp).
(TIF)
Figure S3 Effect of HFD on adipocyte hypertrophy and
adipose angiogenesis in WT and HO-1
+/2 chimeras.
Chimeric mice with transplanted WT or HO-1
+/2 bone marrow
were fed a regular chow (RC) diet or a HFD for 36 weeks. The
animals were sacrificed and the visceral fat tissues were sectioned
and stained with hematoxylin and eosin. A, The adipocyte size
was analyzed using MetaMorph image analysis software (Molec-
ular Devices). B, The adipocyte density was calculated by
counting the number of adipocytes per area. C, Sections were
immunostained with specific antibody against CD31. The CD31
immunofluorescence images were taken from 4 different fields per
section under a fluorescence microscope (6200 magnification).
The CD31
+ area in each field was calculated as [(CD31
+ signal –
background (FITC-goat anti-rat IgG))/total pixels]60.6183 mm
2
(the total real area under 2006 magnification). The vascular
density was defined as CD31
+ area per field (610
26/um
2). The
number of animals in each group was nine or ten. *P,0.05 vs the




Figure S4 Effect of hematopoietic HO-1 haploinsuffi-
ciency on HO activity and intracellular ROS level in
macrophages. Peritoneal macrophages were isolated from WT
and HO-1
+/2 mice receiving thioglycollate injection for 4 days. A,
HO activity in whole cell lysates was determined and expressed as





flow cytometry. C, Quantitative results of CM-H2DCFDA fluores-
cence.ThenumbersofmiceinWTandHO-1
+/2genotypesarethree
and four, respectively. *P,0.05vs WT group.
(TIF)
Figure S5 Hematopoietic HO-1 haploinsufficiency im-
pairs monocyte migration response to MCP-1. A, The
circulating monocytes were isolated from WT and HO-1
+/2 mice
and subjected to APC-conjugated anti-CD11b and PE-conjugated
anti-Ly-6G antibody staining, followed by flow cytometry.
Monocytes were identified as CD11b
+Ly-6G
2 cells. B, WT and
HO-1
+/2 monocytes (5610
4) isolated from each individual mouse
were tested for their migration response to 10 ng/ml of MCP-1.
The experimental procedure was same as described for peritoneal
macrophages except the migration time is 4 hr. The number of
mice in each group is three. Data represented are the migration
responses relative to the WT control group which was set to 100.
*P,0.05 vs WT control;
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